A Phase-IV Non-interventional Study to Assess Virological Effectiveness, Safety, and Tolerability of DTG-based Antiretroviral Therapy in HIV-1 Infected Indian Persons Living with HIV

CONCLUSION: Our results from a large Indian cohort indicate a favourable virological and metabolic response, with good tolerance of DTG-based ART at 24 weeks.PMID:38284697 | DOI:10.2174/011570162X264021231108010324

Source: Current HIV Research - January 29, 2024 Category: Infectious Diseases Authors: Kuldeep Ashta Sumit Arora Rajesh Khanna Anirudh Anilkumar Nishant Raman Charu Mohan Source Type: research